TREATMENT ADHERENCE OF COVID-19 PATIENTS GETTING MEDICATION AT HOME
Introduction: Turkey has adopted outpatient treatment of COVID-19 since the beginning of the pandemic. In the outpatient treatment of COVID-19 in Turkey, only hydroxychloroquine was initially used, favipiravir was added to the treatment, and finally, hydroxychloroquine was removed from the treatment...
Main Authors: | Porsuk Onder Ahmet, Cerit Cigdem |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of medical doctors Sanamed Novi Pazar
2022-07-01
|
Series: | Sanamed |
Subjects: | |
Online Access: | https://www.sanamed.rs/OJS/index.php/Sanamed/article/view/539/291 |
Similar Items
-
Patient-Perceived Impact of the COVID-19 Pandemic on Medication Adherence and Access to Care for Long-Term Diseases: A Cross-Sectional Online Survey
by: Beatriz Santos, et al.
Published: (2024-02-01) -
Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand
by: Nicolas Salvadori, et al.
Published: (2024-06-01) -
Favipiravir in the Treatment of Outpatient COVID-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial
by: Atefeh Vaezi, et al.
Published: (2023-01-01) -
Detecting medication non-adherence in schizophrenia: A comparison of different methods among outpatients from a North Indian center
by: Nidhi Chauhan, et al.
Published: (2023-01-01) -
Managing Medications and Medication Adherence Among US Adults During the Early Phase of the COVID-19 Pandemic
by: Bartlett Ellis RJ, et al.
Published: (2023-02-01)